PAHC
Phibro Animal Health Corp - Class A (PAHC)
Healthcare • NASDAQ • $40.00-7.32%
- Symbol
- PAHC
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $40.00
- Daily Change
- -7.32%
- Market Cap
- $1.62B
- Trailing P/E
- 17.17
- Forward P/E
- 11.78
- 52W High
- $60.08
- 52W Low
- $22.51
- Analyst Target
- $51.20
- Dividend Yield
- +1.20%
- Beta
- 0.61
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health an…
Company websiteResearch PAHC on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.